Epstein SL - Search Results

1

More Divisions for Less Margin Loss: A Strategic Division and Preservation Technique for Deep Galeal Optimization.

Epstein SL, Wilkowski CM, Maden AR, Carroll BT. Epstein SL, et al. Dermatol Surg. 2024 Nov 7. doi: 10.1097/DSS.0000000000004489. Online ahead of print. Dermatol Surg. 2024. PMID: 39508469 No abstract available.

2

Crohn's Disease Presenting as Orofacial Granulomatosis.

Epstein S, Somach S, Gelles L. Epstein S, et al. J Pediatr. 2025 Jan;276:114324. doi: 10.1016/j.jpeds.2024.114324. Epub 2024 Sep 24. J Pediatr. 2025. PMID: 39326836 Free article. No abstract available.

3

Maximizing the potential of biobanks in dermatology research.

Treichel AM, Chen JHK, Epstein S, McCormick TS, Bordeaux JS, Alouani DJ, Cooper KD. Treichel AM, et al. J Dermatol Sci. 2024 Aug;115(2):98-99. doi: 10.1016/j.jdermsci.2024.03.003. Epub 2024 Mar 22. J Dermatol Sci. 2024. PMID: 39030157 No abstract available.

4

Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination.

Misplon JA, Lo C-Y, Crabbs TA, Price GE, Epstein SL. Misplon JA, et al. Among authors: epstein sl. J Virol. 2023 Oct 31;97(10):e0067423. doi: 10.1128/jvi.00674-23. Epub 2023 Oct 13. J Virol. 2023. PMID: 37830821 Free PMC article.

5

Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.

Price GE, Lo CY, Misplon JA, Epstein SL. Price GE, et al. Among authors: epstein sl. J Virol. 2022 Jun 22;96(12):e0032022. doi: 10.1128/jvi.00320-22. Epub 2022 May 31. J Virol. 2022. PMID: 35638848 Free PMC article.

6

Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.

Lo CY, Misplon JA, Li X, Price GE, Ye Z, Epstein SL. Lo CY, et al. Among authors: epstein sl. Vaccine. 2021 Jul 30;39(33):4628-4640. doi: 10.1016/j.vaccine.2021.06.072. Epub 2021 Jul 3. Vaccine. 2021. PMID: 34226103

7

Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model.

Dhakal S, Loube J, Misplon JA, Lo CY, Creisher PS, Mulka KR, Deshpande S, Mitzner W, Klein SL, Epstein SL. Dhakal S, et al. Among authors: epstein sl. J Virol. 2021 Apr 12;95(9):e02359-20. doi: 10.1128/JVI.02359-20. Print 2021 Apr 12. J Virol. 2021. PMID: 33627390 Free PMC article.

8

Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine.

Viboud C, Gostic K, Nelson MI, Price GE, Perofsky A, Sun K, Sequeira Trovão N, Cowling BJ, Epstein SL, Spiro DJ. Viboud C, et al. Among authors: epstein sl. PLoS Pathog. 2020 Sep 24;16(9):e1008583. doi: 10.1371/journal.ppat.1008583. eCollection 2020 Sep. PLoS Pathog. 2020. PMID: 32970783 Free PMC article. Review.

9

The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice.

Rowell J, Lo CY, Price GE, Misplon JA, Crim RL, Jayanti P, Beeler J, Epstein SL. Rowell J, et al. Among authors: epstein sl. PLoS One. 2019 Apr 15;14(4):e0215321. doi: 10.1371/journal.pone.0215321. eCollection 2019. PLoS One. 2019. PMID: 30986224 Free PMC article.

10

Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.

Epstein SL. Epstein SL. Am J Epidemiol. 2018 Dec 1;187(12):2603-2614. doi: 10.1093/aje/kwy145. Am J Epidemiol. 2018. PMID: 30084906 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters